97316 ⎘
Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
TETHERED INTERLEUKIN-2 RECOMBINANT RECEPTORS AND METHODS OF USE
#2SYNTHETIC PATHWAY ACTIVATORS
#3COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#4FUNCTIONAL EXPRESSION OF ECTOPIC TMC1 AND TMC2 IN HETEROLOGOUS CELLS
#5COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#6COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#7COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#8HIGH AFFINITY B7-H6 ANTIBODIES AND ANTIBODY FRAGMENTS
#9COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#10ANTIBODY CHEMICALLY INDUCED DIMERIZER (ABCID) AS MOLECULAR SWITCHES FOR REGULATING CELLULAR THERAPIES
#11CHIMERIC ADIPONECTIN POLYPEPTIDES, EXTRACELLULAR VESICLE COMPRISING THE SAME, AND USES THEREOF
#12MRNAS ENCODING CHIMERIC METABOLIC REPROGRAMMING POLYPEPTIDES AND USES THEREOF
#13COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS
#14CHIMERIC ANTIGEN RECEPTOR (CAR)-T SIGNALING OPTIMIZATION FOR TUNING ANTIGEN ACTIVATION THRESHOLD
#15IGFR-LIKE 2 RECEPTOR AND USES THEREOF
#16ANTI-VACCINIA VIRUS ANTIGEN ANTIBODIES AND RELATED COMPOSITIONS AND METHODS
#17RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF
#18NOVEL CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
#19NOVEL CHIMERIC ANTIGEN RECEPTORS AND LIBRARIES
#20COMPOSITIONS AND METHODS FOR CAR T CELL THERAPY
#21CS1 TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS
#22CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND METHODS OF MAKING AND USING SAME
#23ENGINEERED T CELLS, AND PREPARATION AND USE THEREOF
#24HYBRID PROMOTERS, VECTORS CONTAINING SAME AND METHODS OF USE
#25T CELLS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF
#26Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof
#27MODULAR POLYPEPTIDE LIBRARIES AND METHODS OF MAKING AND USING SAME
#28Cells expressing recombinant growth factor receptors
#29MODIFIED MINI-NUCLEOSOME CORE PROTEINS AND USE IN NUCLEIC ACID DELIVERY
#30RECOMBINANT POLYPEPTIDES FOR MEMBRANE FUSION AND USES THEREOF
#31PROTEIN KINASE C MODULATORS
#32Compositions and methods for targeting CD33-expressing cancers
#33COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY
#34DETECTION OF NOVEL DEGRADATION-RELATED INTERACTIONS
#35DIMERIZATION SWITCHES AND USES THEREOF
#36NON-HUMAN ANIMALS COMPRISING A HUMANIZED TRKB LOCUS
#37PEPTIDE MIMETICS OF DKK3b AND METHODS OF USE
#38CELL
#39INDUCED ACTIVATION IN DENDRITIC CELLS
#40Ciliary Neurotrophic Factor Receptor Ligands and Methods of Using the Same
#41Transcription factor-mediated promotion of direct somatic embryogenesis
#42Recombinant proteins comprising botulinum toxin and cell penetrating peptide and cosmetic composition comprising thereof
#43CHIMERIC ANTIGEN RECEPTORS COMPRISING BCMA-SPECIFIC FIBRONECTIN TYPE III DOMAINS AND USES THEREOF
#44High affinity B7-H6 antibodies and antibody fragments
#45CS1 targeted chimeric antigen receptor-modified T cells
#46Chimeric antigen receptor comprising third signal receptor and use thereof
#47SYNTHETIC SIGNALING CONSTRUCTS AND ITS USE
#48Compositions and methods for CAR T cell therapy
#49NOVEL CHIMERIC ANTIGEN RECEPTORS AND LIBRARIES
#50METHODS AND COMPOSITIONS ENHANCING SURVIVAL AND FUNCTIONALITY OF ANTI-TUMOR AND ANTI-VIRAL T CELLS
#51Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof
#52ENGINEERED IMMUNE CELL CAPABLE OF INDUCING SECRETION OF ANTI-CD47 ANTIBODY
#53Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies
#54Modular polypeptide libraries and methods of making and using same
#55Dual chimeric antigen receptor-t cell which can be regulated, construction method therefor and use thereof
#56Compositions and methods for targeting CD33-expressing cancers
#57INDUCED ACTIVATION IN DENDRITIC CELLS
#58Phosphatidylserine targeting fusion molecules and methods for their use
#59Method for regulating targeting of Cyclin Y (CCNY) protein to synapses
#60Compositions and methods for CAR T cell therapy
#61CALRETICULIN AND FUSION PROTEINS
#62Recombinant polypepties for membrane fusion and uses thereof
#63Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof
#64Ciliary neurotrophic factor receptor ligands and methods of using the same
#65Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
#66HUMANIZED ANTI-MUC1* ANTIBODIES AND USE OF CLEAVAGE ENZYME
#67Therapeutic spalt-like transcription factor 4 (SALL4) peptide
#68Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of same
#69Genetically modified rat comprising a humanized locus
#70Anti-CD7 chimeric antigen receptor and method of use thereof
#71High affinity B7-H6 antibodies and antibody fragments
#72Biosensors for chloride ions
#73Polyethylenimine (PEI)-polypeptide conjugates and methods of use thereof
#74Chimeric T cell
#75Modified chimeric receptors and related compositions and methods
#76CHIMERIC RECEPTORS CONTAINING TRAF-INDUCING DOMAINS AND RELATED COMPOSITIONS AND METHODS
#77Compositions and methods for improving viral vector efficiency
#78Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof
#79METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#80Ubiquitin interacting motif peptides as therapeutics
#81CEACAM6 CAR immune cells to treat cancers
#82CS1 targeted chimeric antigen receptor-modified T cells
#83Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof
#84Anti-EGFR antibody and uses of same
#85FUSION PROTEIN COMPRISING STREPTOCOCCAL ANTIGEN
#86RTEF-1 VARIANTS AND USES THEREOF
#87Induced activation in dendritic cells
#88Method for treating CD40-mediated diseases
#89Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#90Pro-angiogenic peptides and peptide conjugates
#91Induced activation in dendritic cells
#92Fluorescent protein voltage sensors for measuring membrane potential and imaging high-frequency neuronal electrical activity
#93Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#94Recombinant polypeptides for membrane fusion and uses thereof
#95Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#96Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#97Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#98Induced activation in dendritic cells
#99ENGINEERING CORRECTLY FOLDED ANTIBODIES USING INNER MEMBRANE DISPLAY OF TWIN-ARGININE TRANSLOCATION INTERMEDIATES
#100Isolated laminin-421
#101Antithrombotic compounds
#102Methods and Compositions for the Extracellular Transport of Biosynthetic Hydrocarbons and Other Molecules
#103Methods and Compositions for Targeting Heterologous Integral Membrane Proteins to the Cyanobacterial Plasma Membrane
#104RTEF-1 variants and uses thereof
#105Anticoagulant fusion protein anchored to cell membrane
#106Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopeptidases
#107Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver
#108Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same
#109METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#110MODIFIED DENDRITIC CELLS HAVING ENHANCED SURVIVAL AND IMMUNOGENICITY AND RELATED COMPOSITIONS AND METHODS
#111Method for generating tethered proteins
#112Constitutively Translocating Cell Line
#113Compositions and methods for identifying transforming and tumor suppressor genes
#114Induced activation in dendritic cells
#115Conformational and topological protein regulation
#116Peptide-tagged proteins and methods of making and using thereof
#117Camp reporters and high throughput assays
#118Targeted fusion proteins and methods for the characterization of cellular membrane domains
#119Hybrid cells producing monoclonal anti-CD14 antibodies
#120Methods of screening compounds for GRK6 modulating activity
#121Conformational and topological protein regulation
#122Method for producing by cell-free protein synthesis system using thioredoxin-fused protein expression vector
#123Targeted fusion proteins and methods for the characterization of cellular membrane domains
#124Plasmids encoding therapeutic agents
#125Anticoagulant fusion protein anchored to cell membrane
#126Complex formation for the stabilisation and purification of proteins of interest
#127Reagents and methods for detection and characterization of protein-protein interactions, nuclear export and localization sequences and inducible Gal4p-mediated gene expression in yeast
#128Constitutively translocating cell line
#129Conformational and topological protein regulation
#130Conformational and topological protein regulation
#131Conformational and topological protein regulation